Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients
暂无分享,去创建一个
H. Grallert | A. Leiherer | H. Drexel | C. Saely | P. Rein | A. Muendlein | E. Kinz | K. Gasser | A. Lang | N. Stark | A. Peters | A. Peters